Atezolizumab - CaLiGraph

CaLiGraph

Property	Value
rdf:type	Genentech brand Hoffmann-La Roche brand owl:NamedIndividual Orphan drug Therapeutic monoclonal antibody Monoclonal antibody for tumors Drug granted breakthrough therapy designation
rdfs:label	Atezolizumab
owl:sameAs	dbr:Atezolizumab
prov:wasDerivedFrom	http://en.wikipedia.org/wiki/Roche http://en.wikipedia.org/wiki/Genentech http://en.wikipedia.org/wiki/Category:Orphan_drugs http://en.wikipedia.org/wiki/List_of_therapeutic_monoclonal_antibodies http://en.wikipedia.org/wiki/Monoclonal_antibody_therapy http://en.wikipedia.org/wiki/List_of_drugs_granted_breakthrough_therapy_designation http://en.wikipedia.org/wiki/Category:Genentech_brands http://en.wikipedia.org/wiki/Category:Hoffmann-La_Roche_brands http://en.wikipedia.org/wiki/Chugai_Pharmaceutical_Co. http://en.wikipedia.org/wiki/Category:Monoclonal_antibodies_for_tumors http://en.wikipedia.org/wiki/Cancer_immunotherapy http://en.wikipedia.org/wiki/Checkpoint_inhibitor http://en.wikipedia.org/wiki/PD-1_and_PD-L1_inhibitors
skos:prefLabel	Atezolizumab
skos:altLabel	Tecentriq Tecentriq® atezolizumab
clgo:alternativeName	Tecentriq
clgo:casNumber	1380723-44-3
clgo:drugbank	DB11595
clgo:fdaUniiCode	52CMI0WC3Y
clgo:kegg	D10773
clgo:medlinePlus	a616035
is clgo:product of	Genentech

About: clgr:Atezolizumab